Ovarian Neoplasms
Showing 1 - 25 of 220
Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +19 more
- A2B694
- xT CDx with HLA-LOH Assay
-
Duarte, California
- +9 more
Sep 22, 2023
Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)
Not yet recruiting
- Ovarian Neoplasms
- +5 more
- Dostarlimab
- +4 more
- (no location specified)
Sep 3, 2023
Carcinoma, Squamous Cell of Head and Neck, NSCLC, Ovarian Tumors Trial (disitamab vedotin)
Not yet recruiting
- Carcinoma, Squamous Cell of Head and Neck
- +3 more
- disitamab vedotin
- (no location specified)
Aug 15, 2023
Improved Diagnosis of Ovarian Cancer
Recruiting
- Ovarian Neoplasms
- +6 more
-
Aarhus, DenmarkDepartment of Gynaecology and Obstetrics, Aarhus University Hosp
May 1, 2023
Ovarian Tumors, Sarcopenia Trial in Chambéry (Sarcopenia diagnostic test)
Recruiting
- Ovarian Neoplasms
- Sarcopenia
- Sarcopenia diagnostic test
-
Chambéry, Savoie, FranceCentre Hospitalier Metropole Savoie
Apr 17, 2023
Solid Tumor, Haematological Malignancy, Colorectal Tumors Trial in United Kingdom (Trastuzumab, Pertuzumab)
Recruiting
- Solid Tumor
- +10 more
-
Belfast, United Kingdom
- +25 more
Mar 28, 2023
Ovarian Tumors Trial (MRI)
Not yet recruiting
- Ovarian Neoplasms
- MRI
- (no location specified)
Mar 3, 2023
Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)
Recruiting
- Solid Tumor
- +11 more
-
Belfast, United Kingdom
- +16 more
Mar 2, 2023
Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
Recruiting
- Ovarian Neoplasms
- +2 more
-
Aarhus, DenmarkDepartment of Gynaecology and Obstetrics, Aarhus University Hosp
Mar 9, 2023
Ovarian Tumors, Ovarian Diseases Trial (Adebrelimab, Fuzuloparib)
Not yet recruiting
- Ovarian Neoplasms
- Ovarian Diseases
- (no location specified)
Feb 23, 2023
Carcinoma, Ovarian Epithelial, Ovarian Tumors, Fallopian Tube Tumors Trial in Iowa City (AB-1015)
Recruiting
- Carcinoma, Ovarian Epithelial
- +8 more
- AB-1015
-
Iowa City, IowaU. of Iowa Health Care
Jan 30, 2023
Uterine Cervical Tumors, Endometrial Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Worldwide
Recruiting
- Uterine Cervical Neoplasms
- +10 more
- Pembrolizumab/Vibostolimab Co-Formulation
- +11 more
-
Anchorage, Alaska
- +65 more
Jan 27, 2023
Ovarian Tumors, BRCA1 Protein, BRCA2 Protein Trial in Worldwide (KU-0059436 (AZD2281)(PARP inhibitor))
Active, not recruiting
- Ovarian Neoplasms
- +2 more
- KU-0059436 (AZD2281)(PARP inhibitor)
-
Brussels, Belgium
- +4 more
Dec 19, 2022
Ovarian Tumors Trial in United States (Niraparib, Bevacizumab)
Active, not recruiting
- Ovarian Neoplasms
- Niraparib
- Bevacizumab
-
Mobile, Alabama
- +27 more
Nov 23, 2022
Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.
Recruiting
- Pelvic Cancer
- +8 more
- Ultrasound guided tru-cut biopsy
-
Leuven, Belgium
- +3 more
Nov 3, 2022
Ovarian Cysts, Ovarian Cancer, Ovarian Tumors Trial (Detailed symptomregistration)
Recruiting
- Ovarian Cysts
- +3 more
- Detailed symptomregistration
-
Copenhagen, DenmarkClaus Kim Høgdall
Oct 25, 2022
The Canadian/US Integrative Oncology Study
Active, not recruiting
- Breast Neoplasms
- +3 more
-
Scottsdale, Arizona
- +11 more
Oct 21, 2022
Niraparib in Treatment of Adult Approved Indications in South
Recruiting
- Ovarian Neoplasms
-
Busan, Korea, Republic ofInje University Haeundae Paik Hospital
Oct 19, 2022
Ovarian Tumors, Recurrent Ovarian Carcinoma, Relapsed Ovarian Cancer Trial in Beijing (AK112 low dose, AK112 medium dose, AK112
Terminated
- Ovarian Neoplasms
- +3 more
- AK112 low dose
- +2 more
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences and Peking Union Medical Col
Oct 8, 2022